Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Calcium Signaling Deficits in Glia and Autophagic Pathways Contributing to Neurodegenerative Disease.

Mustaly-Kalimi S, Littlefield AM, Stutzmann GE.

Antioxid Redox Signal. 2018 Apr 24. doi: 10.1089/ars.2017.7266. [Epub ahead of print]

PMID:
29634342
2.

Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.

Lacampagne A, Liu X, Reiken S, Bussiere R, Meli AC, Lauritzen I, Teich AF, Zalk R, Saint N, Arancio O, Bauer C, Duprat F, Briggs CA, Chakroborty S, Stutzmann GE, Shelanski ML, Checler F, Chami M, Marks AR.

Acta Neuropathol. 2017 Nov;134(5):749-767. doi: 10.1007/s00401-017-1733-7. Epub 2017 Jun 19.

PMID:
28631094
3.

A Clinically Relevant Closed-Head Model of Single and Repeat Concussive Injury in the Adult Rat Using a Controlled Cortical Impact Device.

Jamnia N, Urban JH, Stutzmann GE, Chiren SG, Reisenbigler E, Marr R, Peterson DA, Kozlowski DA.

J Neurotrauma. 2017 Apr 1;34(7):1351-1363. doi: 10.1089/neu.2016.4517. Epub 2016 Dec 2.

PMID:
27762651
4.

Emerging pathways driving early synaptic pathology in Alzheimer's disease.

Briggs CA, Chakroborty S, Stutzmann GE.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):988-997. doi: 10.1016/j.bbrc.2016.09.088. Epub 2016 Sep 20. Review.

5.

Dynamic Alterations of Rat Nucleus Accumbens Dendritic Spines over 2 Months of Abstinence from Extended-Access Cocaine Self-Administration.

Christian DT, Wang X, Chen EL, Sehgal LK, Ghassemlou MN, Miao JJ, Estepanian D, Araghi CH, Stutzmann GE, Wolf ME.

Neuropsychopharmacology. 2017 Feb;42(3):748-756. doi: 10.1038/npp.2016.168. Epub 2016 Aug 24.

6.

Inhibition of Glycogen Synthase Kinase-3: An Emerging Target in the Treatment of Traumatic Brain Injury.

Shim SS, Stutzmann GE.

J Neurotrauma. 2016 Dec 1;33(23):2065-2076. Epub 2016 May 9. Review.

PMID:
26979735
7.

Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides.

Hinrich AJ, Jodelka FM, Chang JL, Brutman D, Bruno AM, Briggs CA, James BD, Stutzmann GE, Bennett DA, Miller SA, Rigo F, Marr RA, Hastings ML.

EMBO Mol Med. 2016 Apr 1;8(4):328-45. doi: 10.15252/emmm.201505846.

8.

Nitric oxide signaling is recruited as a compensatory mechanism for sustaining synaptic plasticity in Alzheimer's disease mice.

Chakroborty S, Kim J, Schneider C, West AR, Stutzmann GE.

J Neurosci. 2015 Apr 29;35(17):6893-902. doi: 10.1523/JNEUROSCI.4002-14.2015.

9.

Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures.

Chakroborty S, Stutzmann GE.

Eur J Pharmacol. 2014 Sep 15;739:83-95. doi: 10.1016/j.ejphar.2013.11.012. Epub 2013 Dec 6. Review.

PMID:
24316360
10.

β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice.

Briggs CA, Schneider C, Richardson JC, Stutzmann GE.

Neurobiol Aging. 2013 Jun;34(6):1632-43. doi: 10.1016/j.neurobiolaging.2012.12.013. Epub 2013 Jan 18.

11.

Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease.

Chakroborty S, Briggs C, Miller MB, Goussakov I, Schneider C, Kim J, Wicks J, Richardson JC, Conklin V, Cameransi BG, Stutzmann GE.

PLoS One. 2012;7(12):e52056. doi: 10.1371/journal.pone.0052056. Epub 2012 Dec 21.

12.

Withdrawal from cocaine self-administration alters NMDA receptor-mediated Ca2+ entry in nucleus accumbens dendritic spines.

Ferrario CR, Goussakov I, Stutzmann GE, Wolf ME.

PLoS One. 2012;7(8):e40898. doi: 10.1371/journal.pone.0040898. Epub 2012 Aug 3.

13.

Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimer's disease mice.

Chakroborty S, Kim J, Schneider C, Jacobson C, Molgó J, Stutzmann GE.

J Neurosci. 2012 Jun 13;32(24):8341-53. doi: 10.1523/JNEUROSCI.0936-12.2012.

14.

Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.

Chakroborty S, Stutzmann GE.

Sci China Life Sci. 2011 Aug;54(8):752-62. doi: 10.1007/s11427-011-4205-7. Epub 2011 Jul 24. Review.

PMID:
21786198
15.

Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.

Stutzmann GE, Mattson MP.

Pharmacol Rev. 2011 Sep;63(3):700-27. doi: 10.1124/pr.110.003814. Epub 2011 Jul 7. Review.

16.

Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.

Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE.

Neurobiol Aging. 2012 May;33(5):1001.e1-6. doi: 10.1016/j.neurobiolaging.2011.03.011. Epub 2011 Apr 30.

17.

Generation of dendritic Ca2+ oscillations as a consequence of altered ryanodine receptor function in AD neurons.

Goussakov I, Chakroborty S, Stutzmann GE.

Channels (Austin). 2011 Jan-Feb;5(1):9-13. Epub 2011 Jan 1.

PMID:
21139422
18.

NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.

Goussakov I, Miller MB, Stutzmann GE.

J Neurosci. 2010 Sep 8;30(36):12128-37. doi: 10.1523/JNEUROSCI.2474-10.2010.

19.

Repeated cocaine exposure decreases dopamine D₂-like receptor modulation of Ca(2+) homeostasis in rat nucleus accumbens neurons.

Perez MF, Ford KA, Goussakov I, Stutzmann GE, Hu XT.

Synapse. 2011 Feb;65(2):168-80. doi: 10.1002/syn.20831.

20.

Calcium signaling and amyloid toxicity in Alzheimer disease.

Demuro A, Parker I, Stutzmann GE.

J Biol Chem. 2010 Apr 23;285(17):12463-8. doi: 10.1074/jbc.R109.080895. Epub 2010 Mar 8. Review.

21.

Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.

Chakroborty S, Goussakov I, Miller MB, Stutzmann GE.

J Neurosci. 2009 Jul 29;29(30):9458-70. doi: 10.1523/JNEUROSCI.2047-09.2009.

22.

The pathogenesis of Alzheimers disease is it a lifelong "calciumopathy"?

Stutzmann GE.

Neuroscientist. 2007 Oct;13(5):546-59. Review.

PMID:
17901262
23.

Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models.

Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I, Laferla F.

Ann N Y Acad Sci. 2007 Feb;1097:265-77.

PMID:
17413028
24.

Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.

Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I.

J Neurosci. 2006 May 10;26(19):5180-9.

25.

Calcium dysregulation, IP3 signaling, and Alzheimer's disease.

Stutzmann GE.

Neuroscientist. 2005 Apr;11(2):110-5. Review.

PMID:
15746379
26.

Dynamic multiphoton imaging: a live view from cells to systems.

Stutzmann GE, Parker I.

Physiology (Bethesda). 2005 Feb;20:15-21. Review.

28.
30.

Multiphoton-evoked color change of DsRed as an optical highlighter for cellular and subcellular labeling.

Marchant JS, Stutzmann GE, Leissring MA, LaFerla FM, Parker I.

Nat Biotechnol. 2001 Jul;19(7):645-9.

PMID:
11433276
32.

Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone.

Stutzmann GE, McEwen BS, LeDoux JE.

J Neurosci. 1998 Nov 15;18(22):9529-38.

Supplemental Content

Loading ...
Support Center